{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:02:15Z","timestamp":1762542135580,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/dmd.112.048355","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T04:03:11Z","timestamp":1359172991000},"page":"814-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity"],"prefix":"10.1016","volume":"41","author":[{"given":"Christopher C.","family":"Arico-Muendel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Belanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather S.","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo A.","family":"Centrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"DeLorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth G.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Gradhand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Labenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavirayani","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazbeh","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Westlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry F.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.048355_bib1","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1021\/jm901260k","article-title":"Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2","volume":"52","author":"Arico-Muendel","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.048355_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1110\/ps.062278006","article-title":"Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase","volume":"15","author":"Addlagatta","year":"2006","journal-title":"Protein Sci"},{"key":"10.1124\/dmd.112.048355_bib3","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/art.27462","article-title":"Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis","volume":"62","author":"Ashraf","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.112.048355_bib4","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/art.30422","article-title":"Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis","volume":"63","author":"Ashraf","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.112.048355_bib5","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2340","article-title":"Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition","volume":"9","author":"Bainbridge","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/dmd.112.048355_bib6","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1073\/pnas.0404105101","article-title":"A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis","volume":"101","author":"Bernier","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.048355_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1358\/dof.2005.030.05.895807","article-title":"Fumagillin class inhibitors of methionine aminopeptidase-2","volume":"30","author":"Bernier","year":"2005","journal-title":"Drugs Future"},{"key":"10.1124\/dmd.112.048355_bib8","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1021\/ja00748a028","article-title":"Stereochemistry of allylic oxidation with selenium dioxide. Stereospecific oxidation of gem-dimethyl olefins","volume":"93","author":"Bhalerao","year":"1971","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.112.048355_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1124\/jpet.108.148478","article-title":"Involution of collagen-induced arthritis with an angiogenesis inhibitor, PPI-2458","volume":"329","author":"Brahn","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.048355_bib10","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-05-0871","article-title":"A novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin\u2019s lymphoma cell proliferation in vitro and in vivo","volume":"12","author":"Cooper","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.112.048355_bib11","series-title":"Accomplishments in Cancer Research 1997","first-page":"32","article-title":"Tumor angiogenesis","author":"Folkman","year":"1998"},{"key":"10.1124\/dmd.112.048355_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.112.048355_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/157019312800604724","article-title":"Fumagillin and structurally related molecules as source of new drugs","volume":"9","author":"Gamba-Sanchez","year":"2012","journal-title":"Mini Rev Org Chem"},{"key":"10.1124\/dmd.112.048355_bib14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.31.9.1108","article-title":"Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine","volume":"31","author":"Galetin","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.048355_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-5521(97)90198-8","article-title":"Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin","volume":"4","author":"Griffith","year":"1997","journal-title":"Chem Biol"},{"key":"10.1124\/dmd.112.048355_bib16","doi-asserted-by":"crossref","first-page":"10081","DOI":"10.1016\/S0040-4020(00)00979-0","article-title":"Structure elucidation of fumagillin-related natural products","volume":"56","author":"Hal\u00e1sz","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1124\/dmd.112.048355_bib17","first-page":"955","article-title":"Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458","volume":"28","author":"Hannig","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1124\/dmd.112.048355_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.22402","article-title":"Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458","volume":"56","author":"Hannig","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.112.048355_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1124\/dmd.112.048355_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00011-007-7075-5","article-title":"An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis","volume":"57","author":"Lazarus","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1124\/dmd.112.048355_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1248\/cpb.55.1024","article-title":"Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues","volume":"55","author":"Lee","year":"2007","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.112.048355_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14787210.5.4.573","article-title":"Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors","volume":"5","author":"Lefkove","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1124\/dmd.112.048355_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.282.5392.1324","article-title":"Structure of human methionine aminopeptidase-2 complexed with fumagillin","volume":"282","author":"Liu","year":"1998","journal-title":"Science"},{"key":"10.1124\/dmd.112.048355_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2174\/1389450111009011439","article-title":"Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours","volume":"11","author":"Mauriz","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1124\/dmd.112.048355_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1248\/cpb.40.96","article-title":"Chemical modification of fumagillin. I. 6-O-acyl, 6-O-sulfonyl, 6-O-alkyl, and 6-O-(N-substituted-carbamoyl)fumagillols","volume":"40","author":"Marui","year":"1992","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.112.048355_bib26","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/rcm.830","article-title":"The identification of in vitro metabolites of CKD-732 by liquid chromatography\/tandem mass spectrometry","volume":"16","author":"Myung","year":"2002","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.112.048355_bib27","unstructured":"Olson GL, Self C, Lee L, Cook CM, and Birktoft JJ (2003) inventors, Praecis Pharmaceuticals Inc., assignee. Therapeutic agents and methods of use thereof for the modulation of angiogenesis. US Patent 6,548,477. 2003 Apr 15."},{"key":"10.1124\/dmd.112.048355_bib28","first-page":"3036","article-title":"Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes","volume":"55","author":"Placidi","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.112.048355_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/138161209787315855","article-title":"The discovery of antiangiogenic molecules: a historical review","volume":"15","author":"Ribatti","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1124\/dmd.112.048355_bib30","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1073\/pnas.94.12.6099","article-title":"The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2","volume":"94","author":"Sin","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.048355_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-P","article-title":"Quantitation of protein","volume":"182","author":"Stoscheck","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.112.048355_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/08916930903143083","article-title":"Angiogenesis in rheumatoid arthritis","volume":"42","author":"Szekanecz","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1124\/dmd.112.048355_bib33","doi-asserted-by":"crossref","first-page":"11224","DOI":"10.1021\/ja972272g","article-title":"An efficient catalytic asymmetric epoxidation method","volume":"119","author":"Wang","year":"1997","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.112.048355_bib34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/092986712799320709","article-title":"The development of MetAP-2 inhibitors in cancer treatment","volume":"19","author":"Yin","year":"2012","journal-title":"Curr Med Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.048355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:08:01Z","timestamp":1739905681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624097009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090955624097009"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.048355","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.048355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}